|
Seductive fragrance of molecules under patent |
|
|
|
Written by Felix Da Silva (fdasilva@bitnip.com)
|
|
Sunday, 24 February 2008 |
 Most people thought that the only chemecials worth patenting are for pharmaceutical purposes. However, this article states that chemicals that are used to make perfumes and other scented products are also quite profitable and patentable as well.
Thesaron, a chemcial by Takasago International Corporation, became an essential ingredient in a new perfume, Silver Shadow
Altitude, released by Davidoff. Davidoff has had a
scent on the top five perfume best-seller list for the last 20 years which means
that molecule is highly profitable for Takasago.
Thesaron is a perfume industry version of pharmaceuticals like Lipitor,
the commercial name of the active ingredient developed by Pfizer
that lowers blood cholesterol.
Givaudan produces natural and synthetic perfumery raw materials and employs
the perfumers who use these materials to make fragrances. In 2006 Givaudan’s
sales were 2.9 billion Swiss francs ($2.64 billion), and the double-digit sales
growth of its fine-fragrances division was powered by Givaudan’s captives.
As you can see, the scent chemical industry is a highly lucrative one. This is quite an interesting article on the patent of scent molecules, their pharmaceutical counterparts and the dollar figures associated with it.
I recommend you to read this article by the New York Times about the perfume industry, their patentability and the lucrative nature of these molecules.
|
